GlaxoSmithKline Pharma A/S: public contracts won without a rival in Denmark: 2 uncontested awards; 12% of its awards; 0 without a competition; 2 single bid.
Assay record ASY-DK-1RD7VDT10Q · Cite as: Assay Systems, “GlaxoSmithKline Pharma A/S: public contracts won without a rival in Denmark”, https://assay-systems.com/register/dk/uncontested/s/glaxosmithkline-pharma-a-s/
GlaxoSmithKline Pharma A/S won 2 of its 17 public contract awards in Denmark without a rival from 2024-05-14 to 2026-05-12: 0 without a competition and 2 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Amgros I/S with 2.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Amgros I/S gave GlaxoSmithKline Pharma A/S 16 awards: 0 without a competition, 2 after a competition with a single bid. First 2024-05-14, latest 2026-05-12.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2024-11-21 | Amgros I/S 710198-2024 | Single bid open | — |
| 2024-06-18 | Amgros I/S 360757-2024 | Single bid open | — |
Every uncontested award in Denmark · All countries · GlaxoSmithKline Pharma A/S in the register
Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.